# Study of AHB-171 in Chronic Hepatitis B Participants

> **NCT07630727** · PHASE2 · RECRUITING · sponsor: **Ausper Biopharma Co., Ltd.** · enrollment: 138 (estimated)

## Conditions studied

- Hepatitis B, Chronic (CHB)

## Interventions

- **DRUG:** AHB-171 Injection

## Key facts

- **NCT ID:** NCT07630727
- **Lead sponsor:** Ausper Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-24
- **Primary completion:** 2029-03-31
- **Final completion:** 2029-05-31
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07630727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07630727, "Study of AHB-171 in Chronic Hepatitis B Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07630727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*